BSRBR | Newsletter

The British Society for Rheumatology Biologics Register                                                     January 2011

This is the second edition of the BSRBR E-news.  Please forward to any colleagues who might be interested and if they email us, we can add them to the circulation list.  We also welcome feedback on the content and layout.

Editorial

Professor D Isenberg, Chair, BSRBR Steering Committee

Some very important changes are about to take place in the BSRBR.  Read more.

BSRBR opens two new cohorts.

A substantial amendment to the study was approved on 20th December 2010 by the North West REC, allowing the registration of participants starting certolizumab pegol to the BSRBR.

As well as this, it is proposed that the certolizumab cohort is compared with two non-certolizumab reference cohorts.

For more information, click here.